Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-19

Clinical Trial Update: 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations [Phase 4]

View source ↗

Summary

Phase 4 trial update on fixed-combination dorzolamide/timolol and latanoprost/timolol for open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide-timolol (Dorzolamide-timolol)
  • latanoprost/timolol

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Open-angle Glaucoma | Phase 4 | Status: COMPLETED